Table 1.

Demographics of study participants

Treatment group (n = 124)
DFMO + triamcinolone (n = 34)DFMO + placebo (n = 31)Placebo + triamcinolone (n = 31)Placebo + placebo (n = 28)
Age, mean (SD)64.6 (13.3)64.4 (9.2)62.8 (10.3)65.1 (12.4)
    Range40-8648-8043-7935-86
Male, n (%)28 (82.4)24 (77.4)24 (77.4)24 (85.7)
White, non-Hispanic, n (%)33 (97.1)30 (96.8)30 (96.8)27 (96.4)
Education
    High school or less, n (%)8 (23.5)4 (12.9)2 (6.5)7 (25.0)
    Some college/trade, n (%)10 (29.4)16 (51.6)19 (61.3)11 (39.3)
    College graduate, n (%)16 (47.1)11 (35.5)10 (32.3)10 (35.7)